Skip to main content
Clinical Trials/CTRI/2026/01/102099
CTRI/2026/01/102099Not yet recruitingPhase 4

Efficacy of Intranasal Dexmedetomidine in suppressing haemodynamic stress response to Boyle Davis Mouth Gag insertion in patients undergoing Tonsillectomy - A Randomised Double Blinded Placebo Controlled Trial.

Mahatma Gandhi Medical College and Research Institute1 site in 1 country64 target enrollmentStarted: February 3, 2026Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Enrollment
64
Locations
1

Study Overview

Brief Summary

The primary purpose of this study is to evaluate the effectiveness of intranasal dexmedetomidine administered preoperatively in attenuating hemodynamic stress response to  Boyle–Davis mouth gag application during tonsillectomy in paediatric patients (5–12 years) .This study hypothesize that intranasal dexmedetomidine, given as premedication, will reduce hemodynamic stress response , compared with standard care during tonsillectomy.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
5.00 Year(s) to 14.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients aged between 5-14 years of age of either sex posted for elective tonsillectomy.

Exclusion Criteria

  • Patients with contraindications to Dexmedetomidine
  • Patients with history of congenital heart diseases, heart blocks, hypertension,pre existing sinus bradycardia,obstructive sleep apnoea.
  • Patients care givers not giving the consent.

Investigators

Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Narra Pavithra

Mahatma Gandhi Medical College and Research Institute , Pondicherry.

Study Sites (1)

Loading locations...

Similar Trials